TY - JOUR
T1 - Assessment of cervical cancer screening policy in Korea for women over age 65
AU - Lee, Sanghoon
AU - Park, Hyun Tae
AU - Hong, Jin Hwa
AU - Song, Jae Yun
AU - Lee, Jae Kwan
AU - Lee, Nak Woo
AU - Kim, Tak
AU - Lee, Kyu Wan
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/10
Y1 - 2013/10
N2 - Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0%) vs. ≤. 65 (6.6%), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.
AB - Objectives: The purpose of this study was to evaluate the efficacy of cervical cancer screening (CCS) in Korean women over 65. years of age and to determine the age at which CCS becomes inefficacious, so that providers and policy makers can be more informed about when to stop screening. Materials and Methods: The data of 999 women, who underwent CCS followed by colposcopy at the Korea University hospital from January 2007 to May 2012, were retrospectively evaluated. Age groups were classified as <. 21 (n. =. 11), 21-29 (n. =. 128), 30-65 (n. =. 768), and >. 65 (n. =. 92). To evaluate the value of CCS in women older than 65, age groups were simply divided into ≤. 65 or >. 65. Participants were also categorized into five strata of age groups (≤. 55 vs. >. 55, ≤. 60 vs. >. 60, ≤. 65 vs. >. 65, ≤. 70 vs. >. 70, and ≤. 75 vs. >. 75) that were compared to the sample to assess a cutoff-age at which to cease screening based on decreased efficacy. Results: The mean age was 45.5. ±. 13.7 (range14-80). There were no differences in the pathologic results for cervical intraepithelial neoplasia (CIN) values of <. CIN2 vs. ≥. CIN2, or ≤. CIN3 vs. cancer among the groups. There was a significantly higher incidence of cancer compared with ≤. CIN3 in women aged >. 65 (13.0%) vs. ≤. 65 (6.6%), (p. =. 0.037). To assess the cervical cancer incidence (CCI) from the larger number of cases by age, a prediction formula was calculated from a national dataset. CCI (per 100,000) continuously increased by age even for those in their 90s. Conclusion: CCS is still necessary in Korean women older than 65 since there is a substantial CCI rate occurring in these women. It is time to consider new guidelines that include the appropriate age and conditions for discontinuing screening.
KW - Age
KW - Cervical cancer
KW - Guideline
KW - Policy
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=84884986237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884986237&partnerID=8YFLogxK
U2 - 10.1016/j.jgo.2013.03.001
DO - 10.1016/j.jgo.2013.03.001
M3 - Article
C2 - 24472483
AN - SCOPUS:84884986237
VL - 4
SP - 382
EP - 387
JO - Journal of Geriatric Oncology
JF - Journal of Geriatric Oncology
SN - 1879-4068
IS - 4
ER -